Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug therapy for chronic urticaria.

L Juhlin1, M Landor

  • 1Department of Dermatology, University Hospital, Uppsala, Sweden.

Clinical Reviews in Allergy
|January 1, 1992
PubMed
Summary

For chronic urticaria treatment, regular antihistamine use is recommended as the first-line therapy. If antihistamines are insufficient, short-term glucocorticosteroids may be added to manage symptoms effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of cold urticaria by desloratadine.

The Journal of dermatological treatment·2004
Same author

Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.

Acta dermato-venereologica·2002
Same author

Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.

The British journal of dermatology·2002
Same author

Definition, classification, and routine diagnosis of urticaria: a consensus report.

The journal of investigative dermatology. Symposium proceedings·2002
Same author

Management of urticaria: a consensus report.

The journal of investigative dermatology. Symposium proceedings·2002
Same author

Alternative treatments for severely affected patients with urticaria.

The journal of investigative dermatology. Symposium proceedings·2002

Area of Science:

  • Dermatology
  • Allergology
  • Pharmacology

Background:

  • Chronic urticaria presents diverse patient challenges, complicating standardized treatment.
  • Establishing a universal drug therapy regimen is difficult due to symptom variability.

Purpose of the Study:

  • To provide a practical therapeutic outline for managing chronic urticaria.
  • To guide clinicians in selecting appropriate pharmacological interventions.

Main Methods:

  • Recommends regular, daily use of antihistamines as the primary treatment.
  • Suggests switching to alternative H1-blockers if sedation or anticholinergic effects occur.
  • Proposes short-term addition of glucocorticosteroids if antihistamines prove ineffective at full doses.

Main Results:

  • Antihistamines are the initial therapy of choice for most chronic urticaria cases.
  • Less sedating antihistamines are preferred for daytime symptom control.
  • Glucocorticosteroids, typically at prednisone-equivalent doses of 40 mg daily, can effectively manage refractory symptoms for short periods.

Conclusions:

  • A stepwise approach involving antihistamines and short-term glucocorticosteroids offers an effective management strategy for chronic urticaria.
  • The goal of corticosteroid therapy is rapid symptom control followed by discontinuation.
  • Individualized adjustments to antihistamine therapy are crucial for managing side effects and optimizing patient outcomes.

Related Experiment Videos